Exascale Labs Holdings Inc.
Income Statement
| Line Item | FY2026 | FY2025 |
|---|---|---|
| Revenue | $14.8M | $7.0M |
| Cost of Revenue | $12.4M | $5.9M |
| Gross Profit | $2.4M | $1.1M |
| Gross Margin | 16.3% | 15.8% |
| Operating Expenses | ||
| Research & Development | $5.5M | $2.8M |
| SG&A Expense | $1.2M | $363.0K |
| Operating Income | $-4.8M | $-3.0M |
| Operating Margin | -32.4% | -43.4% |
| Interest Expense | — | — |
| Pretax Income | $-12.2M | $-7.7M |
| Income Tax Expense | — | — |
| Net Income | $-12.2M | $-7.7M |
| Net Margin | -82.1% | -109.2% |
| EPS (Basic) | $-8,108.26 | $-5,106.44 |
| EPS (Diluted) | $-8,108.26 | $-5,106.44 |
| Shares Outstanding (Basic) | 1.5K | 1.5K |
| Shares Outstanding (Diluted) | 1.5K | 1.5K |
| Dividends Per Share | — | — |